ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag policy work life balance drug development pharma culture

Best Places to Work Industry 2013
The Scientist | Jun 1, 2013 | 6 min read
Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.
Concerns over Efficacy and Cost of Muscle Wasting Treatments
Ruth Williams | Nov 11, 2020 | 5 min read
Two new medications for treating a rare and deadly neuromuscular disease have high prices and questionable efficacies, say scientists.
Balancing Biases
Jef Akst | Jul 1, 2011 | 7 min read
How cognitive prejudices can influence research decisions, and how the pitfalls of human nature can be avoided.
The New Federalism in Life Sciences Policy
Melvin L. Billingsley and Michele M. Washko | Nov 1, 2006 | 6 min read
What states and the Federal government should do to ensure progress in the life sciences.
Female Frontrunners
Jef Akst | Feb 1, 2012 | 7 min read
How to successfully surmount the challenges women face in becoming biotech industry leaders
The Importance of ADMET in Early Drug Discovery and Development
Sartorius | Jun 3, 2020 | 4 min read
A conversation with Mandy Xu of Pharmaron about characterizing promising pharmacological compounds
The Vaginal Microbiome is Finally Getting Recognized
Hannah Thomasy, PhD, Drug Discovery News | Sep 25, 2023 | 10+ min read
Vaginal dysbiosis has long been a taboo subject, but studying and optimizing the vaginal microbiome could be a game changer for women's health.
Career Supplement | Big Makeover for Big Pharma
Alison McCook | Jun 19, 2005 | 10 min read
Since the New York City life science technology-consulting firm Intrasphere Technologies opened an office in India, Samuel Goldman, cofounder and chief technology officer, says he works fairly bizarre hours, scheduling 6:00 A.M. meetings on a "regular basis."
Life Sciences Salary Survey 2011
Jef Akst and Edyta Zielinska | Dec 1, 2011 | 10+ min read
US salaries are starting to recover after last year’s survey recorded the first-ever drop.
How Orphan Drugs Became a Highly Profitable Industry
Diana Kwon | May 1, 2018 | 10+ min read
Government incentives, advances in technology, and an army of patient advocates have spun a successful market—but abuses of the system and exorbitant prices could cause a backlash.

Run a Search

ADVERTISEMENT